StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3011% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Elutia cash

Cash and short-term investments held at the end of each period.

Elutia's cash was $19.90M at Jun 30, 2026. For fiscal 2025 it was $36.35M, up 174.6% from the year before. The highest annual figure on record is $39.53M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$36.35M+174.6%
FY2024Dec 31, 2024$13.24M-31.3%
FY2023Dec 31, 2023$19.28M+13.5%
FY2022Dec 31, 2022$16.99M-44.2%
FY2021Dec 31, 2021$30.43M-23.0%
FY2020Dec 31, 2020$39.53M+1426.3%
FY2019Dec 31, 2019$2.59M+7.3%
FY2018Dec 31, 2018$2.41M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$19.90M+134.1%
Q1 FY2026Mar 31, 2026$28.49M+64.1%
Q4 FY2025Dec 31, 2025$36.35M+174.6%
Q3 FY2025Sep 30, 2025$4.72M-81.7%
Q2 FY2025Jun 30, 2025$8.50M-53.3%
Q1 FY2025Mar 31, 2025$17.36M+38.3%
Q4 FY2024Dec 31, 2024$13.24M-31.3%
Q3 FY2024Sep 30, 2024$25.74M+77.3%
Q2 FY2024Jun 30, 2024$18.19M+95.7%
Q1 FY2024Mar 31, 2024$12.55M+6.5%
Q4 FY2023Dec 31, 2023$19.28M+13.5%
Q3 FY2023Sep 30, 2023$14.52M-12.1%
Q2 FY2023Jun 30, 2023$9.30M-58.1%
Q1 FY2023Mar 31, 2023$11.79M-61.3%
Q4 FY2022Dec 31, 2022$16.99M-24.6%
Q2 FY2022Jun 30, 2022$16.51M-41.7%
Q1 FY2022Mar 31, 2022$22.18M-27.1%
Q4 FY2021Dec 31, 2021$30.43M-23.0%
Q3 FY2021Sep 30, 2021$22.54M+1360.0%
Q2 FY2021Jun 30, 2021$28.30M+2758.8%
Q1 FY2021Mar 31, 2021$30.41M+5510.7%
Q4 FY2020Dec 31, 2020$39.53M+1426.3%
Q3 FY2020Sep 30, 2020$1.54M+465.6%
Q2 FY2020Jun 30, 2020$990.00K-59.0%
Q1 FY2020Mar 31, 2020$542.00K–
Q4 FY2019Dec 31, 2019$2.59M–
Q3 FY2019Sep 30, 2019$273.00K–
Q4 FY2018Dec 31, 2018$2.41M–

More Elutia figures

See a number that looks wrong?